[Treatment of epidermophytosis with bradex-vioform].
D064751:Ammonium Compounds; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D007464:Clioquinol; D006219:Halogens; D006846:Hydrocarbons, Halogenated / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D014005:Tinea / Q000628:therapy*; D014309:Tripelennamine / Q000627:therapeutic use*
D064751:Ammonium Compounds; D000891:Anti-Infective Agents, Local; D006219:Halogens; D006846:Hydrocarbons, Halogenated; D000644:Quaternary Ammonium Compounds; D014309:Tripelennamine; D007464:Clioquinol
ANTISEPTICS, HALOGEN/therapeutic use; ANTISEPTICS, QUATERNARY AMMONIUM/therapeutic use; RINGWORM/therapy; TRIPELENNAMINE/therapeutic use
Zur Behandlung der Epidermophytien mit Bradex-Vioform.